自噬
溶酶体
小胶质细胞
神经炎症
细胞生物学
下调和上调
TFEB
化学
神经毒性
神经科学
生物
炎症
免疫学
生物化学
细胞凋亡
基因
酶
有机化学
毒性
作者
Yixian Li,Peng Yang,Ran Meng,Shuting Xu,Lingling Zhou,Kang Qian,Pengzhen Wang,Yunlong Cheng,Dongyu Sheng,Minjun Xu,Tianying Wang,Jing Wu,Jinxu Cao,Qizhi Zhang
标识
DOI:10.1016/j.apsb.2023.10.009
摘要
Intraneuronal dysproteostasis and extraneuronal microenvironmental abnormalities in Alzheimer’s disease (AD) collectively culminate in neuronal deterioration. In the context of AD, autophagy dysfunction, a multi-link obstacle involving autophagy downregulation and lysosome defects in neurons/microglia is highly implicated in intra/extraneuronal pathological processes. Therefore, multidimensional autophagy regulation strategies co-manipulating “autophagy induction” and “lysosome degradation” in dual targets (neuron and microglia) are more reliable for AD treatment. Accordingly, we designed an RP-1 peptide-modified reactive oxygen species (ROS)-responsive micelles (RT-NM) loading rapamycin or gypenoside XVII. Guided by RP-1 peptide, the ligand of receptor for advanced glycation end products (RAGE), RT-NM efficiently targeted neurons and microglia in AD-affected region. This nano-combination therapy activated the whole autophagy-lysosome pathway by autophagy induction (rapamycin) and lysosome improvement (gypenoside XVII), thus enhancing autophagic degradation of neurotoxic aggregates and inflammasomes, and promoting Aβ phagocytosis. Resultantly, it decreased aberrant protein burden, alleviated neuroinflammation, and eventually ameliorated memory defects in 3×Tg-AD transgenic mice. Our research developed a multidimensional autophagy nano-regulator to boost the efficacy of autophagy-centered AD therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI